EMCURE PHARMACEUTICALS
Back to Balance Sheet
|
EMCURE PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,700 Cr | ₹1,888 Cr | ₹1,044 Cr | ₹817 Cr | ₹459 Cr |
What is the latest Net Current Assets ratio of EMCURE PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,700 Cr |
| Mar2025 | ₹1,888 Cr |
| Mar2024 | ₹1,044 Cr |
| Mar2023 | ₹817 Cr |
| Mar2022 | ₹459 Cr |
How is Net Current Assets of EMCURE PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,700 Cr | -9.95 | |
| Mar2025 | ₹1,888 Cr | 80.80 | |
| Mar2024 | ₹1,044 Cr | 27.83 | |
| Mar2023 | ₹817 Cr | 77.83 | |
| Mar2022 | ₹459 Cr | - | |
Compare Net Current Assets of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹42,020.4 Cr | 17.7% | 15.6% | 70% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹446,276.0 Cr | 5.2% | 4.3% | 8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹273,565.0 Cr | 3.6% | 7.6% | 50.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹180,332.0 Cr | 3.4% | 0.7% | 32.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,532.0 Cr | 2.3% | 14% | 13.6% | Stock Analytics | |
| CIPLA | ₹113,831.0 Cr | 2% | 6% | -6.7% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | 17.7% |
15.6% |
70% |
| SENSEX | 8.8% |
10.9% |
-4% |
You may also like the below Video Courses